Search

everythinglearnresearchcommunity

for

Search:↓

High testosterone increases heart disease risk in women with PCOS.

Nonclassic adrenal hyperplasia is a genetic condition that can cause early puberty and fertility problems, treated with specific steroids.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

A woman's adrenal tumor disappeared after treatment with cyproterone acetate.

Women with PCOS have lower ghrelin levels and a weaker response to sugar, which might affect their feeling of fullness and lead to overeating.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Low iron levels are a significant risk factor for hair loss, while high vitamin D levels might be a response to hair loss, not a cause.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Women with PCOS tend to have higher anxiety and depression levels compared to healthy women.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Polycystic ovary syndrome is a complex condition that affects women's mental, reproductive, and metabolic health throughout their lives.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.

Testing basal 17-HP levels is a good way to screen for nonclassic adrenal hyperplasia in women with high androgen levels.

Older men with lower levels of available testosterone are more likely to be frail.

Women with PCOS have different levels of certain fats and proteins in their blood, which could help diagnose the condition.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

Higher DHT levels are linked to fewer hypogonadism symptoms in men with normal testosterone levels.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

Finasteride and spironolactone both reduce hirsutism, but finasteride lowers androgen levels more.